| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| ESLICARBAZEPINE (is an active metabolite)
| ESLICARBAZEPINE | NERVOUS SYSTEM | - | VD 56.6 LITER (65 KILOGRAM) PPB 40 PERCENT Cl 2.4 LITER / HOUR (EQN) HT 16 HOUR | VOLTAGE-GATED SODIUM CHANNELS | Sodium channel alpha subunit UNIPROT P35498 SCN1A more at DrugCentral | EMA | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| ESLICARBAZEPINE ACETATE (has an active metabolite)
| ESLICARBAZEPINE ACETATE | NERVOUS SYSTEM | ORAL | VOLTAGE-GATED SODIUM CHANNELS | Sodium channel alpha subunit UNIPROT P35498 SCN1A more at DrugCentral | EMA | ||||
